LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
To determine your risk of developing heart disease
Screening: as part of a regular health exam with a lipid profile when no risk factors for heart disease are present; once every four to six years in adults; children should have a lipid profile screening at least once between the ages of 9 and 11 and then again between the ages of 17 and 21.
Monitoring: may be done more frequently and at regular intervals as part of a lipid profile when risk factors for heart disease are present, when prior results showed high risk levels, and/or when undergoing treatment for unhealthy lipid levels
A blood sample drawn from a vein in your arm or from a fingerstick
If this test is to be performed as part of a complete lipid profile, fasting for 9 to 12 hours typically will be required; only water is permitted. Your healthcare practitioner may decide that you may be tested without fasting. Follow any instructions you are given and tell the person drawing your blood whether or not you have fasted. For youths without risk factors, testing may be done without fasting.
High-density lipoprotein (HDL cholesterol, HDL-C) is one of the classes of lipoproteins that carry cholesterol in the blood. HDL-C consists primarily of protein with a small amount of cholesterol. It is considered to be beneficial because it removes excess cholesterol from tissues and carries it to the liver for disposal. Hence, HDL cholesterol is often termed "good" cholesterol. The test for HDL cholesterol measures the amount of HDL-C in blood.
High levels of cholesterol have been shown to be associated with the development of hardening of the arteries (atherosclerosis) and heart disease. When cholesterol levels in the blood increase (not enough is removed by HDL), it may be deposited on the walls of blood vessels. These deposits, termed plaques, can build up, causing vessel walls to become more rigid, and may eventually narrow the openings of blood vessels, constricting the flow of blood.
A higher level of blood HDL-C is usually associated with a lower risk of developing plaques, lowering the risk of heart attack or stroke.
A blood sample is obtained by inserting a needle into a vein in the arm. Sometimes a drop of blood is collected by puncturing the skin on a fingertip. This fingerstick sample is typically used when HDL-C is being measured on a portable testing device, for example, at a health fair.
Since this test is usually performed as part of a complete lipid profile, fasting for 9 to 12 hours before sample collection is typically required; only water is permitted. Your healthcare practitioner may decide that you may be tested without fasting. Follow any instructions you are given and tell the person drawing your blood whether or not you have fasted. For youths without risk factors, testing may be done without fasting.
The test for high-density lipoprotein cholesterol (HDL-C) is used as part of a lipid profile to screen for unhealthy levels of lipids and to determine an individual's risk of developing heart disease and to help make decisions about what treatment to use if there is borderline or high risk. The other components of a lipid profile typically include total cholesterol, LDL cholesterol (LDL-C), and triglycerides.
HDL-C is considered to be beneficial, the so-called "good" cholesterol, because it removes excess cholesterol from tissues and carries it to the liver for disposal.
As part of a lipid profile, HDL-C may also be used to monitor the effectiveness of treatment for unhealthy lipid levels. Treatment options may include lifestyle changes such as diet or exercise programs or lipid-lowering drugs such as statins.
HDL-C may be ordered as part of a lipid profile during a health checkup. It is recommended that all adults with no risk factors for heart disease be tested every four to six years.
As part of a lipid profile, HDL-C may be ordered as a follow-up test when someone has a high result on a cholesterol screening test.
HDL-C, as part of the lipid profile, may be ordered more frequently for those who have one or more risk factors for heart disease. Major risk factors include:
Screening with a lipid profile is recommended for children as well as adults. Children should be tested at least once between the ages of 9 and 11 and once again between the ages of 17 and 21. As with adults, additional testing may be required for young people with other risk factors or if screening shows that levels are above the accepted levels. Some of the risk factors include a family history of heart disease or health problems such as diabetes, high blood pressure, or being overweight. Healthcare practitioners may order lipid profile screening for children under the age of 9 if a parent has high cholesterol, according to the American Academy of Pediatrics.
HDL-C levels may also be ordered at regular intervals to evaluate the success of lifestyle changes such as diet and exercise or smoking cessation aimed at increasing someone's level of HDL-C. Guidelines from the American College of Cardiology and the American Heart Association recommend that adults taking statins have a fasting lipid profile done 4 to 12 weeks after starting therapy and then every 3 to 12 months thereafter to assure that the drug is working.
In general, healthy lipid levels help to maintain a healthy heart and lower the risk of heart attack or stroke. A healthcare practitioner will take into consideration the results of the HDL-C and the other components of a lipid profile as well as other risk factors to help determine a person's overall risk of heart disease, whether treatment is necessary and, if so, which treatment will best help to lower the person's risk.
In 2002, the National Cholesterol Education Program (NCEP) Adult Treatment Panel III provided guidelines for evaluating lipid levels and determining treatment. However, in 2013, the American College of Cardiology and the American Heart Association issued new guidelines for adults that made recommendations on who should receive cholesterol-lowing therapy. (For more details, see the Lipid Profile article).
However, use of the updated guidelines remains controversial. Many still use the older guidelines from the NCEP ATP III to evaluate lipid levels and CVD risk:
For children, teens and young adults:
Some laboratories report a ratio of total cholesterol to HDL cholesterol. The ratio is obtained by dividing the total cholesterol by the HDL cholesterol. For example, if a person has a total cholesterol result of 200 mg/dL and an HDL cholesterol level of 50 mg/dL, the ratio would be stated as 4 (or 4:1). A desirable ratio is below 5 (5:1); the optimum ratio is 3.5 (3.5:1). The American Heart Association recommends that the absolute numbers for total blood cholesterol and HDL cholesterol levels be used because they are more useful than the ratio in determining appropriate treatment for patients.
HDL cholesterol should be measured when a person is not ill. Cholesterol is temporarily low during acute illness, immediately following a heart attack, or during stress (like from surgery or an accident). You should wait at least six weeks after any illness to have cholesterol measured.
In women, HDL cholesterol may change during pregnancy. Women should wait at least six weeks after having a baby to have HDL-C measured.
Low HDL-C is not usually a target for treatment with medication. While some drugs used to lower LDL-C can also raise HDL-C, these drugs are not typically prescribed based on HDL-C levels. Certain lifestyle changes, however, may be recommended to help increase your HDL-C level. Since smoking can decrease HDL-C levels, quitting smoking (if you are a smoker) is a good way to increase HDL-C. Exercise is another good way to increase HDL-C. Alcohol consumption in moderation (1 to 2 drinks per day) has been reported to increase HDL-C, but there is some controversy about whether this is beneficial. Most physicians do not recommend increasing alcohol intake to increase HDL-C cholesterol.
High HDL-C has generally been found to be protective, decreasing the risk of coronary artery disease (CAD) in most people. However, some recent studies have shown that in some people with high HDL-C, the HDL-C is not protective and may, in fact, result in higher risk for CAD than in people with normal HDL-C levels. In one study, it was shown that people with CAD and high HDL-C had underlying genetic anomalies in enzymes important in lipid turnover (cholesterol ester transfer protein and hepatic triglyceride lipase). Another study showed that high levels of abnormally large HDL-C particles were associated with increased risk of CAD. Further research is needed to determine what conditions contribute to unexpectedly high risk of CAD in the presence of high HDL-C.
LOINC Observation Identifiers Names and Codes (LOINC®) is the international standard for identifying health measurements, observations, and documents. It provides a common language to unambiguously identify things you can measure or observe that enables the exchange and aggregation of clinical results for care delivery, outcomes management, and research. Learn More.
Listed in the table below are the LOINC with links to the LOINC detail pages. Please note when you click on the hyperlinked code, you are leaving Lab Tests Online and accessing Loinc.org.
|LOINC||LOINC Display Name|
|2095-8||Cholesterol in HDL/Cholesterol.total [Mass ratio]|
|70200-1||Cholesterol in HDL/Cholesterol.total [Molar ratio]|
|18263-4||Cholesterol in HDL (S/P ultracentrifugate) [Mass/Vol]|
|2085-9||Cholesterol in HDL [Mass/Vol]|
|27340-9||Cholesterol in HDL Ql|
|14646-4||Cholesterol in HDL [Moles/Vol]|
Sources Used in Current Review
Devkota, B. (2014 January 16 Updated). HDL Cholesterol. Medscape Drugs & Diseases. Available online at http://emedicine.medscape.com/article/2087757-overview#showall. Accessed on 5/01/16.
Singh, V. (2013 June 19 Updated). Low HDL Cholesterol. Medscape Drugs & Diseases. Available online at http://emedicine.medscape.com/article/127943-overview. Accessed on 5/01/16.
Singh, V. (2014 December 18 Updated). High HDL Cholesterol. Medscape Drugs & Diseases. Available online at http://emedicine.medscape.com/article/121187-overview. Accessed on 5/01/16.
(© 1995– 2016). Cholesterol, HDL, Serum. Mayo Clinic Mayo Medical Laboratories. Available online at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/8429. Accessed on 5/01/16.
(2016 March 28 Updated). About Cholesterol. American Heart Association. Available online at http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About-Cholesterol_UCM_001220_Article.jsp#.Vy9WX3q9b5M. Accessed on 5/01/16.
Couzin-Frankel, J. (2016 March 10). Why high 'good cholesterol' can be bad news. Science v 352 (6286). Available online at http://www.sciencemag.org/news/2016/03/why-high-good-cholesterol-can-be-bad-news. Accessed on 5/01/16.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934.
Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly Jr DD, DePalma SM, Minissian MB, Orringer CE, Smith SC. 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2016. Available as pdf at http://content.onlinejacc.org/article.aspx?articleID=2510936#tab1.
Sources Used in Previous Reviews
Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.
American Heart Association. "What are healthy levels of cholesterol?" Article available online at http://126.96.36.199/presenter.jhtml?identifier=183
National Heart, Lung, Blood Institute. National Cholesterol Education Program Guidelines, Cholesterol, ATP III. Pp 31-34. PDF available for download at http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accessed July 2008.
Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier; 2006. pp 351-355.
MayoClinic.com. Cholesterol Levels, What numbers should you aim for? (June 21, 2008). Available online at http://www.mayoclinic.com/health/cholesterol-levels/CL00001. Accessed July 2008.
American Heart Association. What Your Cholesterol Level Means. (April 7, 2008). Previously available online at http://188.8.131.52/presenter.jhtml?identifier=183#HDL. Accessed July 2008.
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Pp 252-253.
Ken-ichi Hirano, et al. Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase. Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1849-1856. Available online at http://atvb.ahajournals.org/cgi/content/full/atvbaha;15/11/1849?eaf. Accessed May 2010.
MedWire News: Dangerous edge to very high HDL-C levels. J Am Coll Cardiol 2008; 51: 634-642. Available online at http://www.lipidsonline.org/news/article.cfm?aid=5936. Accessed May 2010.
Lia Tremblay (LifeWire). Are High HDL Levels the Answer to Cholesterol Problems? Why High HDL Levels May Not Be Good Enough. Available online at http://cholesterol.about.com/lw/Health-Medicine/Conditions-and-diseases/Is-Increasing-HDL-Levels-the-Answer-to-Cholesterol-Problems-.htm. Accessed May 2010.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Sep 2002. PDF available for download at http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accessed July 21, 2013.
(December 2011) Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. December 2011. Vol 128. Supplement 5. PDF available for download at http://pediatrics.aappublications.org/site/misc/2009-2107.pdf. Accessed July 21, 2013.
(©2012) American Heart Association. Cholesterol Levels. Available online at http://www.heart.org/HEARTORG/Conditions/Cholesterol/Cholesterol_UCM_001089_SubHomePage.jsp. Accessed July 21, 2013.
(November 2012) American Association of Family Physicians. High Cholesterol. Available online at http://familydoctor.org/familydoctor/en/diseases-conditions/high-cholesterol.html. Accessed July 19, 2013.
Voight, B.F. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. The Lancet. August 2012. Vol 380. Issue 9841. Available online at: http://www.sciencedirect.com/science/article/pii/S0140673612603122. Accessed July 2013.